FORM 9

NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED
SECURITIES

(or securities convertible or exchangeable into listed securities1)

Name of Listed Issuer: Symbol(s):

IM Cannabis Corp. (the "Issuer"). 

IMCC

Date:    October 7, 2022

Is this an updating or amending Notice: X Yes ☐ No 

If yes provide date(s) of prior Notices:  N/A.

Issued and Outstanding Securities of Issuer Prior to Issuance:  74,582,821 common shares.

Pricing

Date of news release announcing proposed issuance:  August 19, 2022 or

Date of confidential request for price protection: _____________________.

Closing Market Price on Day Preceding the news release: USD$0.501 or

Day preceding request for price protection: ______________________________________________.

Closing

Number of securities to be issued: 1,112,504 common shares

Issued and outstanding securities following issuance: 75,695,325 common shares

Instructions:

1. For private placements (including debt settlement), complete tables 1A and 1B in Part 1 of this form.

2. Complete Table 1A - Summary for all purchasers, excluding those identified in Item 8.

3. Complete Table 1B - Related Persons only for Related Persons

4. If shares are being issued in connection with an acquisition (either as consideration or to raise funds for a cash acquisition) please proceed to Part 2 of this form.

____________________

1 The closing price of the Company's common shares on the Nasdaq Capital Market on August 18, 2022 was USD$0.48.


5. An issuance of non-convertible debt does not have to be reported unless it is a significant transaction as defined in Policy 7, in which case it is to be reported on Form 10 - Notice of Proposed Transaction

6. Post the completed Form 9 to the CSE website in accordance with Policy 6 - Distributions.  In addition, the completed form must be delivered to listings@thecse.com with an appendix that includes the information in Table 1B for ALL placees.


Part 1. Private Placement

Table 1A - Summary

Each jurisdiction in which
purchasers reside

Number of
Purchasers

Price per
Security

Total dollar value
(USD$) raised in the
jurisdiction

British Columbia, Canada 

1

USD$0.50

USD$556,252

 

 

   
       

 

 

 

 

Total number of purchasers:

1

 

 

Total dollar value of distribution in all jurisdictions:

USD$556,252

Table 1B - Related Persons

Full Name &
Municipality
of
Residence
of Placee

Number of
Securities
Purchased
or to be
Purchased

Purchase
price per
Security
(USD$)

Conversion

Price (if

Applicable)

(USD$)

Prospectus
Exemption

Total Securities
Previously
Owned,
Controlled or
Directed

Payment
Date(1)

Describe
relations-hip
to Issuer (2)

L5 Capital
Inc.2

4177
Rockridge
Road
West
Vancouver,
British
Columbia
V7W 1A3

1,112,504

$0.50

N/A

Accredited
Investor

265,000
common
shares and
securities
convertible into
32,500 common
shares

October
4, 2022

Executive
Chairman /
Director

____________________

2 L5 Capital Inc. is a private entity controlled by Marc Lustig, who is the Executive Chairman and Director of the Issuer. Following the completion of the private placement described herein, Mr. Lustig beneficially owns, controls or directs an aggregate of 2,064,448 common shares, 550,000 restricted share units and securities convertible into 96,678 common shares.



1An issuance of non-convertible debt does not have to be reported unless it is a significant transaction as defined in Policy 7, in which case it is to be reported on Form 10.

1. Total amount of funds to be raised: USD$556,252                                                     .

2. Provide full details of the use of the proceeds.  The disclosure should be sufficiently complete to enable a reader to appreciate the significance of the transaction without reference to any other material. 

 The Issuer intends to use the proceeds from the private placement for general working capital purposes.

3. Provide particulars of any proceeds which are to be paid to Related Persons of the Issuer:  N/A.

4. If securities are issued in forgiveness of indebtedness, provide details of the debt agreement(s) or and the agreement to exchange the debt for securities.

5. Description of securities to be issued:

 (a) Class  Common shares.

 (b) Number  1,112,504.

 (c) Price per security  USD$0.503.

 (d) Voting rights  Each common share is entitled to one vote.

6. Provide the following information if warrants, (options) or other convertible securities are to be issued:

 (a) Number  N/A.

(b) Number of securities eligible to be purchased on exercise of warrants (or options)  N/A.

 (c) Exercise price  N/A.

 (d) Expiry date  N/A.

(d) Other  N/A.

____________________

3 The closing price of the Company's common shares on the Nasdaq Capital Market on August 18, 2022 was USD$0.48.


7. Provide the following information if debt securities are to be issued:

 (a) Aggregate principal amount  N/A.

 (b) Maturity date  N/A.

 (c) Interest rate  N/A.

 (d) Conversion terms  N/A.

 (e) Default provisions  N/A.

8. Provide the following information for any agent's fee, commission, bonus or finder's fee, or other compensation paid or to be paid in connection with the placement (including warrants, options, etc.):

(a) Details of any dealer, agent, broker or other person receiving compensation in connection with the placement (name, and if a corporation, identify persons owning or exercising voting control over 20% or more of the voting shares if known to the Issuer): N/A.

(b) Cash  N/A.

(c) Securities  N/A.

(e) Expiry date of any options, warrants etc.  N/A.

(f) Exercise price of any options, warrants etc.  N/A.

9. State whether the sales agent, broker, dealer or other person receiving compensation in connection with the placement is Related Person or has any other relationship with the Issuer and provide details of the relationship N/A.

10. Describe any unusual particulars of the transaction (i.e. tax "flow through" shares, etc.).

 N/A.

11. State whether the private placement will result in a change of control.

 N/A.

12. Where there is a change in the control of the Issuer resulting from the issuance of the private placement shares, indicate the names of the new controlling shareholders.  N/A.

13. Each purchaser has been advised of the applicable securities legislation restricted or seasoning period.  All certificates for securities issued which are subject to a hold period bear the appropriate legend restricting their transfer until the expiry of the applicable hold period required by National Instrument 45-102 Resale of Securities.




Name of
Party (If not
an
individual,
name all
insiders of
the Party)

Number
and Type
of
Securities
to be
Issued

Dollar
value per
Security
(CDN$)

Conversion
price (if
applicable)

Prospectus
Exemption

Total
Securities,
Previously
Owned,
Controlled or
Directed by
Party

Describe
relationship

to Issuer(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Indicate if Related Person

7. Details of the steps taken by the Issuer to ensure that the vendor has good title to the assets being acquired:  N/A.

8. Provide the following information for any agent's fee, commission, bonus or finder's fee, or other compensation paid or to be paid in connection with the acquisition (including warrants, options, etc.): N/A.

(a) Details of any dealer, agent, broker or other person receiving compensation in connection with the acquisition (name, and if a corporation, identify persons owning or exercising voting control over 20% or more of the voting shares if known to the Issuer):                                           .

(b) Cash ________________________________________________________________ .

(c) Securities ___________________________________________________________ .

(d) Other ________________________________________________________________ .

(e) Expiry date of any options, warrants etc. ___________________________

(f) Exercise price of any options, warrants etc. ________________________ .

9. State whether the sales agent, broker or other person receiving compensation in connection with the acquisition is a Related Person or has any other relationship with the Issuer and provide details of the relationship. N/A.

10. If applicable, indicate whether the acquisition is the acquisition of an interest in property contiguous to or otherwise related to any other asset acquired in the last 12 months.  N/A.



Certificate Of Compliance

The undersigned hereby certifies that:

1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance on behalf of the Issuer.

2. As of the date hereof there is not material information concerning the Issuer which has not been publicly disclosed.

3. the Issuer has obtained the express written consent of each applicable individual to:

(a) the disclosure of their information to the Exchange pursuant to this Form or otherwise pursuant to this filing; and

(b) the collection, use and disclosure of their information by the Exchange in the manner and for the purposes described in Appendix A or as otherwise identified by the Exchange, from time to time

4. The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in CSE Policy 1).

5. All of the information in this Form 9 Notice of Issuance of Securities is true.

Dated October 7, 2022.

 

Oren Shuster                                       

  Name of Director or Senior Officer
   
  "Oren Shuster"
  Signature
   
  Chief Executive Officer
  Official Capacity


Appendix A

PERSONAL INFORMATION COLLECTION POLICY REGARDING FORM 9

The Canadian Securities Exchange and its subsidiaries, affiliates, regulators and agents (collectively, "CSE or the "Exchange") collect and use the information (which may include personal or other information) which has been provided in Form 9 for the following purposes:

 To determine whether an individual is suitable to be associated with a Listed Issuer;

 To determine whether an issuer is suitable for listing;

 To determine whether allowing an issuer to be listed or allowing an individual to be associated with a Listed Issuer could give rise to investor protection concerns or could bring the Exchange into disrepute;

 To conduct enforcement proceedings;

 To ensure compliance with Exchange Requirements and applicable securities legislation; and

 To fulfil the Exchange's obligation to regulate its marketplace.

The CSE also collects information, including personal information, from other sources, including but not limited to securities regulatory authorities, law enforcement and self-regulatory authorities, regulation service providers and their subsidiaries, affiliates, regulators and agents. The Exchange may disclose personal information to these entities or otherwise as provided by law and they may use it for their own investigations.

The Exchange may use third parties to process information or provide other administrative services. Any third party will be obliged to adhere to the security and confidentiality provisions set out in this policy.

All personal information provided to or collected by or on behalf of The Exchange and that is retained by The Exchange is kept in a secure environment. Only those employees who need to know the information for the purposes listed above are permitted access to the information or any summary thereof. Employees are instructed to keep the information confidential at all times.

Information about you that is retained by the Exchange and that you have identified as inaccurate or obsolete will be corrected or removed.

If you wish to consult your file or have any questions about this policy or our practices, please write the Chief Privacy Officer, Canadian Securities Exchange, 220 Bay Street - 9th Floor, Toronto, ON, M5J 2W4.